In 2023, Biovault worked alongside 6 NHS trusts to process 1,552 cellular therapy products and to release 753, making us a leading provider of PBSC services.
Quality & Safety, Regulatory Partnerships
What can fertility care learn from the Ovom Care insolvency? Explore how robust processing, storage and contingency planning can protect patients and precious biological material.
Date Security, Regulatory Partnerships
Biovault Technical operates a clinical-grade data security model tailored for advanced therapies and biological storage. By integrating annual NHS Information Governance, HTA standards, and Cyber Essentials Plus compliance with a centralised LIMS, Biovault ensures complete data integrity, donor traceability, and cyber resilience across every stage of tissue processing and storage.
Cellular Therapies, Quality & Safety
Explore the zero-margin-for-error custody chain in PBSC processing. Learn how Biovault Technical meets HTA and JACIE standards to ensure transplant viability.
Cellular Therapies, Innovation
To mark Clinical Trials Day, we explore 5 landmark international trials redefining cellular therapy. From record-breaking oncology survival data to functional cures for severe autoimmunity and HIV, discover the breakthroughs transforming medicine from the lab to the bedside.
